BioCryst Pharmaceuticals ROA 2006-2018 | BCRX

Current and historical return on assets (ROA) values for BioCryst Pharmaceuticals (BCRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. BioCryst Pharmaceuticals ROA for the three months ending September 30, 2018 was -58.48%.
BioCryst Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.09B $0.17B -58.93%
2018-06-30 $-0.08B $0.14B -47.81%
2018-03-31 $-0.08B $0.16B -48.90%
2017-12-31 $-0.07B $0.18B -43.07%
2017-09-30 $-0.05B $0.19B -38.86%
2017-06-30 $-0.05B $0.11B -45.07%
2017-03-31 $-0.05B $0.13B -47.72%
2016-12-31 $-0.06B $0.09B -61.04%
2016-09-30 $-0.07B $0.09B -69.17%
2016-06-30 $-0.07B $0.08B -64.57%
2016-03-31 $-0.05B $0.10B -39.69%
2015-12-31 $-0.04B $0.12B -31.79%
2015-09-30 $-0.04B $0.14B -26.62%
2015-06-30 $-0.03B $0.15B -22.38%
2015-03-31 $-0.05B $0.13B -37.36%
2014-12-31 $-0.05B $0.14B -40.09%
2014-09-30 $-0.04B $0.14B -42.05%
2014-06-30 $-0.04B $0.14B -52.96%
2014-03-31 $-0.04B $0.04B -75.68%
2013-12-31 $-0.03B $0.05B -63.49%
2013-09-30 $-0.04B $0.05B -73.10%
2013-06-30 $-0.04B $0.04B -73.08%
2013-03-31 $-0.04B $0.05B -62.30%
2012-12-31 $-0.04B $0.06B -56.32%
2012-09-30 $-0.04B $0.06B -54.30%
2012-06-30 $-0.05B $0.08B -54.38%
2012-03-31 $-0.05B $0.08B -53.99%
2011-12-31 $-0.06B $0.08B -55.17%
2011-09-30 $-0.05B $0.09B -48.96%
2011-06-30 $-0.05B $0.11B -44.35%
2011-03-31 $-0.04B $0.12B -38.34%
2010-12-31 $-0.03B $0.11B -29.50%
2010-09-30 $-0.01B $0.11B -7.29%
2010-06-30 $-0.01B $0.12B -8.11%
2010-03-31 $-0.01B $0.13B -8.14%
2009-12-31 $-0.01B $0.14B -16.42%
2009-09-30 $-0.02B $0.06B -26.76%
2009-06-30 $-0.02B $0.07B -21.12%
2009-03-31 $-0.02B $0.07B -23.01%
2008-12-31 $-0.03B $0.09B -23.75%
2008-09-30 $-0.04B $0.10B -30.90%
2008-06-30 $-0.04B $0.11B -29.94%
2008-03-31 $-0.03B $0.13B -26.88%
2007-12-31 $-0.03B $0.14B -26.98%
2007-09-30 $-0.04B $0.14B -41.69%
2007-06-30 $-0.04B $0.08B -57.14%
2007-03-31 $-0.05B $0.07B -58.44%
2006-12-31 $-0.04B $0.07B -51.46%
2006-09-30 $-0.04B $0.08B -43.97%
2006-06-30 $-0.03B $0.09B -39.88%
2006-03-31 $-0.03B $0.10B -41.13%
2005-12-31 $-0.03B $0.10B -47.16%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.883B $0.025B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.922B 11.07
Zoetis (ZTS) United States $40.810B 27.94
Grifols (GRFS) Spain $12.660B 15.45
Jazz Pharmaceuticals (JAZZ) Ireland $8.354B 11.99
Ionis Pharmaceuticals (IONS) United States $7.136B 0.00
Neurocrine Biosciences (NBIX) United States $6.508B 1435.40
Tilray (TLRY) United States $6.139B 0.00
Nektar Therapeutics (NKTR) United States $5.913B 8.48
Catalent (CTLT) United States $4.978B 20.88
Impax Laboratories (AMRX) United States $4.840B 25.73
Sage Therapeutics (SAGE) United States $4.751B 0.00
United Therapeutics (UTHR) United States $4.646B 7.60
Loxo Oncology (LOXO) United States $4.148B 0.00
TESARO (TSRO) United States $4.055B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.391B 12.56
FibroGen (FGEN) United States $3.313B 0.00
USANA Health Sciences (USNA) United States $2.807B 23.89
Endo (ENDP) Ireland $2.118B 3.24
Xencor (XNCR) United States $1.984B 0.00
Endocyte (ECYT) United States $1.967B 0.00
Heron Therapeutics (HRTX) United States $1.946B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.850B 250.00
Corcept Therapeutics (CORT) United States $1.779B 26.12
Ironwood Pharmaceuticals (IRWD) United States $1.761B 0.00
Aerie Pharmaceuticals (AERI) United States $1.687B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.686B 0.00
Zogenix (ZGNX) United States $1.671B 0.00
PTC Therapeutics (PTCT) United States $1.626B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.430B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.398B 19.66
Tricida (TCDA) United States $1.296B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.287B 0.00
Esperion Therapeutics (ESPR) United States $1.241B 0.00
Portola Pharmaceuticals (PTLA) United States $1.225B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.187B 0.00
TherapeuticsMD (TXMD) United States $0.856B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.789B 0.00
ImmunoGen (IMGN) United States $0.772B 0.00
Radius Health (RDUS) United States $0.697B 0.00
Forty Seven (FTSV) United States $0.656B 0.00
Collegium Pharmaceutical (COLL) United States $0.597B 0.00
Karyopharm Therapeutics (KPTI) United States $0.577B 0.00
Siga Technologies (SIGA) United States $0.556B 0.00
ChemoCentryx (CCXI) United States $0.505B 39.96
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.492B 0.00
Flexion Therapeutics (FLXN) United States $0.488B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 27.40
Rigel Pharmaceuticals (RIGL) United States $0.450B 0.00
GlycoMimetics (GLYC) United States $0.444B 0.00
Xeris Pharmaceuticals (XERS) United States $0.417B 0.00
Dermira (DERM) United States $0.413B 0.00
CASI Pharmaceuticals (CASI) United States $0.411B 0.00
Akebia Therapeutics (AKBA) United States $0.403B 0.00
Odonate Therapeutics (ODT) United States $0.396B 0.00
Translate Bio (TBIO) United States $0.377B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
ArQule (ARQL) United States $0.360B 0.00
KalVista Pharmaceuticals (KALV) United States $0.347B 0.00
Tyme Technologies (TYME) United States $0.334B 0.00
Concert Pharmaceuticals (CNCE) United States $0.320B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.320B 0.00
OptiNose (OPTN) United States $0.311B 0.00
Majesco Entertainment (PTE) United States $0.310B 0.00
Aratana Therapeutics (PETX) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.287B 0.00
Minerva Neurosciences (NERV) United States $0.285B 0.00
Tapimmune (MRKR) United States $0.276B 0.00
Dova Pharmaceuticals (DOVA) United States $0.254B 0.00
Depomed (ASRT) United States $0.251B 9.36
Mast Therapeutics (SVRA) United States $0.249B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.247B 0.00
IMV INC (IMV) Canada $0.241B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.240B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Ocular Therapeutix (OCUL) United States $0.207B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.205B 0.00
Galectin Therapeutics (GALT) United States $0.203B 0.00
Affimed (AFMD) Germany $0.201B 0.00
Zafgen (ZFGN) United States $0.201B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.182B 0.00
Lannett Co Inc (LCI) United States $0.179B 1.55
Opexa Therapeutics (ACER) United States $0.170B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.167B 0.00
MEI Pharma (MEIP) United States $0.166B 0.00
Molecular Templates (MTEM) United States $0.165B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.165B 0.00
ContraFect (CFRX) United States $0.157B 0.00
Nature's Sunshine Products (NATR) United States $0.154B 0.00
Neon Therapeutics (NTGN) United States $0.152B 0.00
Recro Pharma (REPH) United States $0.149B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.142B 0.00
ElectroCore (ECOR) United States $0.141B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.140B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
MediWound (MDWD) Israel $0.128B 0.00
Cardiome Pharma (CORV) Canada $0.124B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.123B 0.00
Ardelyx (ARDX) United States $0.119B 0.00
Adherex Technologies (FENC) United States $0.115B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
DURECT (DRRX) United States $0.108B 0.00
Champions Oncology (CSBR) United States $0.107B 0.00
Rafael Holdings (RFL) United States $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
ProNAi Therapeutics (SRRA) Canada $0.094B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.074B 7.31
CTI BioPharma (CTIC) United States $0.071B 0.00
Achaogen (AKAO) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.070B 0.00
Melinta Therapeutics (MLNT) United States $0.069B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
BioLineRx (BLRX) Israel $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 36.63
Neos Therapeutics (NEOS) United States $0.058B 0.00
KemPharm (KMPH) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.055B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.037B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.03
Capnia (SLNO) United States $0.034B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.028B 0.00
Novan (NOVN) United States $0.028B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.027B 0.00
IsoRay (ISR) United States $0.027B 0.00
Trillium Therapeutics (TRIL) Canada $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.024B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Biomerica (BMRA) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
SCYNEXIS (SCYX) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
PharmAthene (ALT) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.30
Aviragen Therapeutics (VXRT) United States $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.015B 0.00
Shineco (TYHT) China $0.013B 1.45
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Aradigm (ARDM) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00